Acute leukemias in children with Down syndrome. by Zwaan, C, Reinhardt, D, Hitzler, J, Vyas, P

Assessing children’s competence to consent in research by a standardized tool: a validity study by Hein Irma M, Troost Pieter W, Lindeboom Robert, de Vries Martine C, Zwaan C, Lindauer Ramón J L

Get full text

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML. by Hasle, H, Abrahamsson, J, Arola, M, Karow, A, O'Marcaigh, A, Reinhardt, D, Webb, D, van Wering, E, Zeller, B, Zwaan, C, Vyas, P

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia. by Buitenkamp, T, Pieters, R, Zimmermann, M, de Haas, V, Richards, S, Vora, A, Mitchell, C, Schwab, C, Harrison, C, Moorman, A, van den Heuvel-Eibrink, MM, Zwaan, C

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia by Buitenkamp, T, Pieters, R, Zimmermann, M, De Haas, V, Richards, S, Vora, A, Mitchell, C, Schwab, C, Harrison, C, Moorman, A, Van Den Heuvel-Eibrink, MM, Zwaan, C

Gene expression profiling in MDS and AML: potential and future avenues. by Theilgaard-Mönch, K, Boultwood, J, Ferrari, S, Giannopoulos, K, Hernandez-Rivas, J, Kohlmann, A, Morgan, M, Porse, B, Tagliafico, E, Zwaan, C, Wainscoat, J, Van den Heuvel-Eibrink, MM, Mills, K, Bullinger, L

Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. by Bourquin, J, Subramanian, A, Langebrake, C, Reinhardt, D, Bernard, O, Ballerini, P, Baruchel, A, Cavé, H, Dastugue, N, Hasle, H, Kaspers, G, Lessard, M, Michaux, L, Vyas, P, van Wering, E, Zwaan, C, Golub, T, Orkin, S

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations by Buitenkamp, T, Pieters, R, Gallimore, N, van der Veer, A, Meijerink, J, Beverloo, H, Zimmermann, M, de Haas, V, Richards, S, Vora, A, Mitchell, C, Russell, L, Schwab, C, Harrison, C, Moorman, A, van den Heuvel-Eibrink, MM, den Boer, M, Zwaan, C

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. by Buitenkamp, T, Pieters, R, Gallimore, N, van der Veer, A, Meijerink, J, Beverloo, H, Zimmermann, M, de Haas, V, Richards, S, Vora, A, Mitchell, C, Russell, L, Schwab, C, Harrison, C, Moorman, A, van den Heuvel-Eibrink, MM, den Boer, M, Zwaan, C

Selection of reperfusion therapy for individual patients with evolving myocardial infarction by VanderWerf, F, Vahanian, A, Gulba, D, Muller, J, Arnold, A, Bar, F, Vermeer, F, Verheugt, F, Boersma, H, VanEs, G, Deckers, J, Lenderink, T, Simoons, M, Steyerberg, E, VanderZwaan, C, deBoer, M, Zijlstra, F, Wilcox, R, Sleight, P, Selker, H, Califf, R, Granger, C, Lee, K, Ohman, M, Weaver, D